{"product_id":"cjc1295-ipamorelin-blend","title":"CJC-1295 \/ Ipamorelin Blend","description":"\u003cp\u003e\u003cstrong\u003eCJC-1295 (No DAC) \/ Ipamorelin Blend\u003c\/strong\u003e combines two research peptides that signal through different receptor systems connected with growth-hormone biology. CJC-1295 (No DAC) is studied through the GHRH receptor, while ipamorelin is studied through the ghrelin receptor.\u003c\/p\u003e\u003cp\u003eResearchers use the combination to examine how two distinct upstream signals may interact within the same growth-hormone research axis.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eTechnical Identity:\u003c\/strong\u003e This blend is commonly characterized by two peptide components: a CJC-1295 (No DAC) \/ modified GHRH-related peptide and ipamorelin, a synthetic growth-hormone secretagogue peptide.\u003c\/p\u003e\u003cp\u003eAzyven Research CJC-1295 \/ Ipamorelin Blend is supplied exclusively for laboratory research and analytical use.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is CJC-1295 \/ Ipamorelin Blend?\u003c\/h3\u003e\u003cp\u003eThis formulation combines a GHRH-related peptide with a selective growth hormone secretagogue. Each component engages a different receptor system involved in regulating pituitary growth-hormone release.\u003c\/p\u003e\u003ch3\u003eWhy is CJC-1295 \/ Ipamorelin Blend studied?\u003c\/h3\u003e\u003cp\u003eThe blend has attracted research interest because GHRH-receptor signaling and ghrelin-receptor signaling represent complementary routes into the growth-hormone axis.\u003c\/p\u003e\u003cp\u003eResearchers use the combination to examine receptor interactions, endocrine signaling, growth-hormone release, and how multiple upstream signals can converge on the same biological system.\u003c\/p\u003e\u003ch3\u003eWhat research areas are associated with CJC-1295 \/ Ipamorelin Blend?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eGHRH-Receptor Research\u003c\/strong\u003e\u003cbr\u003eCJC-1295 (No DAC) contributes GHRH-related signaling to the formulation.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eGhrelin-Receptor Research\u003c\/strong\u003e\u003cbr\u003eIpamorelin is studied for selective activity at the growth hormone secretagogue receptor.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eGrowth-Hormone Signaling Research\u003c\/strong\u003e\u003cbr\u003eBoth components are associated with pathways regulating pituitary growth-hormone release.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eGrowth Hormone \/ IGF-1 Axis Research\u003c\/strong\u003e\u003cbr\u003eThe blend provides a model for studying downstream endocrine responses connected with growth-hormone signaling.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eMulti-Pathway Endocrine Research\u003c\/strong\u003e\u003cbr\u003eResearchers can investigate how distinct receptor systems influence a shared hormonal pathway.\u003c\/p\u003e\u003ch3\u003eWhat have studies found?\u003c\/h3\u003e\u003cp\u003eThe two components have separate research histories that help explain the scientific rationale for studying them together.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eCJC-related signaling\u003c\/strong\u003e\u003cbr\u003eResearch on GHRH analogues has examined pituitary growth-hormone release and downstream endocrine signaling.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eIpamorelin signaling\u003c\/strong\u003e\u003cbr\u003eStudies have reported selective growth-hormone secretagogue activity associated with ghrelin-receptor signaling.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eComplementary pathways\u003c\/strong\u003e\u003cbr\u003eThe formulation allows researchers to examine two receptor systems that can converge on growth-hormone release.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eEvidence context\u003c\/strong\u003e\u003cbr\u003eFindings for either component individually do not establish the behavior of the combined formulation. The blend should be evaluated as its own research system.\u003c\/p\u003e\u003ch3\u003eHow does CJC-1295 \/ Ipamorelin Blend relate to other Azyven products?\u003c\/h3\u003e\u003cp\u003eAzyven also offers \u003cstrong\u003eCJC-1295 (No DAC)\u003c\/strong\u003e and \u003cstrong\u003eIpamorelin\u003c\/strong\u003e as standalone research peptides, allowing each receptor pathway to be examined independently.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSermorelin\u003c\/strong\u003e and \u003cstrong\u003eTesamorelin\u003c\/strong\u003e provide additional GHRH-related comparison points within the Azyven catalog.\u003c\/p\u003e\u003cp\u003eResearchers can ask Aria Jr. to compare the individual components, receptor systems, or blend format.\u003c\/p\u003e\u003ch3\u003eWhat am I purchasing?\u003c\/h3\u003e\u003cp\u003eAzyven Research CJC-1295 \/ Ipamorelin Blend is supplied as a lyophilized combination research material.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eAvailable Strength:\u003c\/strong\u003e 10 mg\u003cbr\u003e\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilized powder\u003cbr\u003e\u003cstrong\u003eProduct Type:\u003c\/strong\u003e Research Peptide Blend\u003cbr\u003e\u003cstrong\u003eIntended Use:\u003c\/strong\u003e Laboratory research only\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Use Only:\u003c\/strong\u003e Azyven Research products are intended for laboratory research purposes only. They are not intended for human or veterinary use, consumption, administration, or clinical application.\u003c\/p\u003e","brand":"Azyven Research","offers":[{"title":"10MG","offer_id":60251423211601,"sku":"CP10","price":69.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1069\/8869\/9729\/files\/CJC_IPA10MG.png?v=1788108416","url":"https:\/\/azyvenresearch.com\/products\/cjc1295-ipamorelin-blend","provider":"Azyven Research ","version":"1.0","type":"link"}